Influence of diabetes and congestive heart failure (CHF) on selection of first-line (1L) treatment for metastatic renal cell carcinoma (mRCC)
Publication
, Conference
Gong, J; George, D; Mhatre, S; Lin, SW; Surinach, A; Wallen, H; Vohra, R; Simpson, J; Ogale, S; Pal, SK
Published in: Annals of Oncology
October 1, 2016
Duke Scholars
Published In
Annals of Oncology
DOI
EISSN
1569-8041
ISSN
0923-7534
Publication Date
October 1, 2016
Volume
27
Start / End Page
vi282
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Gong, J., George, D., Mhatre, S., Lin, S. W., Surinach, A., Wallen, H., … Pal, S. K. (2016). Influence of diabetes and congestive heart failure (CHF) on selection of first-line (1L) treatment for metastatic renal cell carcinoma (mRCC). In Annals of Oncology (Vol. 27, p. vi282). https://doi.org/10.1093/annonc/mdw373.37
Gong, J., D. George, S. Mhatre, S. W. Lin, A. Surinach, H. Wallen, R. Vohra, J. Simpson, S. Ogale, and S. K. Pal. “Influence of diabetes and congestive heart failure (CHF) on selection of first-line (1L) treatment for metastatic renal cell carcinoma (mRCC).” In Annals of Oncology, 27:vi282, 2016. https://doi.org/10.1093/annonc/mdw373.37.
Gong J, George D, Mhatre S, Lin SW, Surinach A, Wallen H, et al. Influence of diabetes and congestive heart failure (CHF) on selection of first-line (1L) treatment for metastatic renal cell carcinoma (mRCC). In: Annals of Oncology. 2016. p. vi282.
Gong, J., et al. “Influence of diabetes and congestive heart failure (CHF) on selection of first-line (1L) treatment for metastatic renal cell carcinoma (mRCC).” Annals of Oncology, vol. 27, 2016, p. vi282. Scopus, doi:10.1093/annonc/mdw373.37.
Gong J, George D, Mhatre S, Lin SW, Surinach A, Wallen H, Vohra R, Simpson J, Ogale S, Pal SK. Influence of diabetes and congestive heart failure (CHF) on selection of first-line (1L) treatment for metastatic renal cell carcinoma (mRCC). Annals of Oncology. 2016. p. vi282.
Published In
Annals of Oncology
DOI
EISSN
1569-8041
ISSN
0923-7534
Publication Date
October 1, 2016
Volume
27
Start / End Page
vi282
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis